| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▲ | 1.53▼ | 1.53▼ | 1.51▲ | 1.48▲ |
| MA10 | 1.52▼ | 1.53▼ | 1.53▼ | 1.46▲ | 1.42▲ |
| MA20 | 1.52▼ | 1.52▼ | 1.51▼ | 1.47▲ | 1.16▲ |
| MA50 | 1.50▲ | 1.47▲ | 1.46▲ | 1.35▲ | 1.17▲ |
| MA100 | 1.46▲ | 1.44▲ | 1.46▲ | 1.15▲ | 1.50▲ |
| MA200 | 1.43▲ | 1.46▲ | 1.53▼ | 1.25▲ | 3.30▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.003▼ | -0.003▼ | -0.001▼ | 0.039▲ |
| RSI | 48.062▼ | 49.501▼ | 51.054▲ | 53.896▲ | 56.098▲ |
| STOCH | 20.385 | 70.513 | 70.513 | 75.900 | 45.342 |
| WILL %R | -69.231 | -69.231 | -69.231 | -23.529▲ | -53.416 |
| CCI | -45.752 | -86.620 | -65.707 | 112.903▲ | 50.003 |
|
Friday, January 15, 2021 12:57 AM
(GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target ...
|
|
Thursday, January 14, 2021 05:13 AM
BOTHELL, Wash., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology ...
|
|
Thursday, January 14, 2021 05:12 AM
© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/01/21 | 1.59 | 1.59 | 1.50 | 1.51 | 1,647,500 |
| 14/01/21 | 1.48 | 1.58 | 1.46 | 1.53 | 1,183,700 |
| 13/01/21 | 1.53 | 1.56 | 1.46 | 1.49 | 1,569,200 |
| 12/01/21 | 1.46 | 1.58 | 1.44 | 1.55 | 2,109,200 |
| 11/01/21 | 1.40 | 1.50 | 1.40 | 1.46 | 1,225,330 |
| 08/01/21 | 1.41 | 1.48 | 1.38 | 1.43 | 1,355,500 |
| 07/01/21 | 1.38 | 1.44 | 1.38 | 1.41 | 930,700 |
| 06/01/21 | 1.44 | 1.46 | 1.35 | 1.38 | 1,331,700 |
| 05/01/21 | 1.41 | 1.46 | 1.36 | 1.43 | 1,285,179 |
| 04/01/21 | 1.35 | 1.42 | 1.25 | 1.41 | 2,194,481 |
|
|
||||
|
|
||||
|
|